Science News
from research organizations

Study points to a safer, better test for chromosomal defects in the fetus

Date:
January 10, 2013
Source:
Cell Press
Summary:
A noninvasive, sequencing-based approach for detecting chromosomal abnormalities in the developing fetus is safer and more informative in some cases than traditional methods, according to a new study. This method, which analyzes fetal DNA in the mother's blood, could provide women with a cost-effective way to find out whether their unborn baby will have major developmental problems without risking a miscarriage.
Share:
       
FULL STORY

This clinical sample has a karyotype with a small deletion in chromosome 7 (blue circle). Another small deletion is detected in chromosome 8 (red circle). Expanded regions show z7j and z8j 1 Mb and 100 kb bin data. The figure shows a 1 Mb deletion at bin number 150 Mb on Chr 7 (A). At higher resolution (B), this deletion is found to be 300 kb long, in the region from 150.3 Mb to 150.6 Mb of Chr 7. Note: The putative copy-number gain seen in Chr 7 at bin number 156 in the 1 Mb data is not seen in the same region in the 100 kb data. The figure also shows a 2 Mb deletion on Chr 8 (A) covering bins 46 Mb and 47 Mb. At higher resolution (B), this resolves into a 900 kb deletion, covering the region from 46.9 Mb to 47.7 Mb of Chr 8.
Credit: American Journal of Human Genetics, Srinivasan et al. Figure 4.

A noninvasive, sequencing-based approach for detecting chromosomal abnormalities in the developing fetus is safer and more informative in some cases than traditional methods, according to a study published Jan. 10 by Cell Press in The American Journal of Human Genetics. This method, which analyzes fetal DNA in the mother's blood, could provide women with a cost-effective way to find out whether their unborn baby will have major developmental problems without risking a miscarriage.

"Our study is the first to show that almost all the information that is available from an invasive procedure is also available noninvasively from a simple maternal blood draw," says senior study author Richard Rava of Verinata Health.

Metaphase karyotypes -- pictures of chromosomes taken through the microscope -- have traditionally been used to detect abnormalities associated with developmental delay, intellectual disability, congenital defects, and autism. Recently, a method called a chromosome microarray, which uses molecular probes to detect gains or losses of DNA segments within chromosomes, has been shown to provide more detailed information than a metaphase karyotype. But both of these approaches require invasive procedures that involve removing tissue from the placenta or inserting a needle into the amniotic sac to collect fluid. As a result, they increase the risk of infection and could harm the fetus during pregnancy.

Massively parallel sequencing (MPS) of fetal DNA in the mother's blood offers a safer alternative for the detection of chromosomal abnormalities across the fetal genome. But it has not been known whether MPS is as accurate as chromosome microarrays. In the new study, Rava and his team found that MPS was capable of detecting a variety of chromosomal abnormalities as accurately as chromosome microarrays.

"Such a noninvasive test could have clinical utility in the near future, particularly for women who either have a medical contraindication or lack access to an invasive procedure," Rava says. "This work suggests an exciting future path toward routine noninvasive detection of abnormalities in the entire fetal genome."


Story Source:

The above post is reprinted from materials provided by Cell Press. Note: Materials may be edited for content and length.


Journal Reference:

  1. Anupama Srinivasan, Diana W. Bianchi, Hui Huang, Amy J. Sehnert, Richard P. Rava. Noninvasive Detection of Fetal Subchromosome Abnormalities via Deep Sequencing of Maternal Plasma. The American Journal of Human Genetics, 2013; DOI: 10.1016/j.ajhg.2012.12.006

Cite This Page:

Cell Press. "Study points to a safer, better test for chromosomal defects in the fetus." ScienceDaily. ScienceDaily, 10 January 2013. <www.sciencedaily.com/releases/2013/01/130110121018.htm>.
Cell Press. (2013, January 10). Study points to a safer, better test for chromosomal defects in the fetus. ScienceDaily. Retrieved August 30, 2015 from www.sciencedaily.com/releases/2013/01/130110121018.htm
Cell Press. "Study points to a safer, better test for chromosomal defects in the fetus." ScienceDaily. www.sciencedaily.com/releases/2013/01/130110121018.htm (accessed August 30, 2015).

Share This Page: